Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marrone seeks to raise $60-70 million from IPO

The US biopesticide company, Marrone Bio Innovations (MBI - Davis, California), is seeking to raise approximately $60-70 million from its proposed initial public offering (IPO) of common stock. The company filed a registration statement with the US Securities and Exchange Commission in relation to the IPO earlier this month (Agrow No 668, p 2). A preliminary prospectus issued by one of the underwriters, Piper Jaffray & Co, indicates that MBI aims to sell 4.2 million shares of common stock on the Nasdaq Global Market at $14-17/share.  At the completion of the offering, there will be some 16.9 million shares of MBI common stock outstanding, assuming that the underwriters do not exercise their 30-day right to purchase 630,000 additional shares.  In addition to the 2 million shares subject to stock options outstanding as of March 31st 2013, options to purchase just under 1.1 million shares were vested as of that date and will be eligible for sale 180 days after the IPO date, which has yet to be set.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG000104

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel